Review



sunitinib (multitarget rtk inhibitor)  (MultiTarget Pharmaceuticals)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    MultiTarget Pharmaceuticals sunitinib (multitarget rtk inhibitor)
    Preclinical antivascular and antiangiogenic studies that used vessel-calibre MRI
    Sunitinib (Multitarget Rtk Inhibitor), supplied by MultiTarget Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/sunitinib (multitarget rtk inhibitor)/product/MultiTarget Pharmaceuticals
    Average 90 stars, based on 1 article reviews
    sunitinib (multitarget rtk inhibitor) - by Bioz Stars, 2026-03
    90/100 stars

    Images

    1) Product Images from "Vessel calibre—a potential MRI biomarker of tumour response in clinical trials"

    Article Title: Vessel calibre—a potential MRI biomarker of tumour response in clinical trials

    Journal: Nature reviews. Clinical oncology

    doi: 10.1038/nrclinonc.2014.126

    Preclinical antivascular and antiangiogenic studies that used vessel-calibre MRI
    Figure Legend Snippet: Preclinical antivascular and antiangiogenic studies that used vessel-calibre MRI

    Techniques Used: Inhibition, Disruption



    Similar Products

    sunitinib (multitarget rtk inhibitor)  (MultiTarget Pharmaceuticals)
    90
    MultiTarget Pharmaceuticals sunitinib (multitarget rtk inhibitor)
    Preclinical antivascular and antiangiogenic studies that used vessel-calibre MRI
    Sunitinib (Multitarget Rtk Inhibitor), supplied by MultiTarget Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/sunitinib (multitarget rtk inhibitor)/product/MultiTarget Pharmaceuticals
    Average 90 stars, based on 1 article reviews
    sunitinib (multitarget rtk inhibitor) - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    oral multitargeted rtk inhibitor sunitinib  (Pfizer Inc)
    90
    Pfizer Inc oral multitargeted rtk inhibitor sunitinib
    Preclinical antivascular and antiangiogenic studies that used vessel-calibre MRI
    Oral Multitargeted Rtk Inhibitor Sunitinib, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/oral multitargeted rtk inhibitor sunitinib/product/Pfizer Inc
    Average 90 stars, based on 1 article reviews
    oral multitargeted rtk inhibitor sunitinib - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Preclinical antivascular and antiangiogenic studies that used vessel-calibre MRI

    Journal: Nature reviews. Clinical oncology

    Article Title: Vessel calibre—a potential MRI biomarker of tumour response in clinical trials

    doi: 10.1038/nrclinonc.2014.126

    Figure Lengend Snippet: Preclinical antivascular and antiangiogenic studies that used vessel-calibre MRI

    Article Snippet: Sunitinib (multitarget RTK inhibitor); 60 mg/kg per day , MDA-MB-435 melanoma in mice (10) 118 , ↓ ( P <0.05) , ↓ ( P <0.05) , Day 7.

    Techniques: Inhibition, Disruption